Rights Issue (Företrädesemission) 2022
-
Biovica Anmalningssedel utan foretrade -
Biovica International AB (publ) - Prospectus 18 Nov 2022 -
biovica-beslutar-om-en-fullt-garanterad-foretradesemission-om-cirka-148-msek -
biovica-resolves-on-a-fully-guaranteed-rights-issue-of-approximately-sek-148-million -
Annual Report Biovica-21-22-ENG -
Annual Report Biovica-20-21-ENG -
5567746150_Registreringsbevis_2022-11-18 -
Årsredovisning Biovica-21-22-SWE -
Årsredovisning Biovica-20-21-SWE -
q1-2022-2023-Biovica-SWE -
q1-2022-2023-Biovica-ENG -
Bolagsordning 2021-08-31 -
biovica-publishes-prospectus-in-connection-with-the-companys-fully-guaranteed-rights-issue-of-approximately-sek-148-million -
biovica-publicerar-prospekt-i-samband-med-bolagets-fullt-garanterade-foretradesemission-om-cirka-148-msek -
https://biovica.com/mfn_news/biovica-beslutar-om-en-fullt-garanterad-foretradesemission-om-cirka-148-msek/ -
https://biovica.com/mfn_news/biovica-resolves-on-a-fully-guaranteed-rights-issue-of-approximately-sek-148-million/
>4,500
Numbers of patients in studies
28
Publications
32
Pharma Projects